The strong beat-and-raise, accelerating free cash flow, and a large buyback authorization create a powerful bullish setup. The Cylinder Health acquisition adds a new growth vector in GI care. Traders should watch for the Q3 close of the acquisition and any further upward guidance revisions on the earnings call.
Price Chart
Executive Summary
Hinge Health reported Q2 2026 revenue of $212.8M (+53% YoY), well above the $201.5M consensus, and GAAP diluted EPS of $0.52 vs. a -$13.10 loss in Q2 2025. Non-GAAP diluted EPS was $0.59 vs. $0.30 a year ago. The company raised full-year 2026 revenue guidance to $856-860M (midpoint $858M, +46% YoY), signed a definitive agreement to acquire Cylinder Health for $105M in cash to enter gastrointestinal care, and the board approved a $300M increase to the share repurchase program (total authorization now $496.5M). The combination of a strong beat-and-raise quarter, a strategic tuck-in acquisition into a large adjacent market, and a massive buyback authorization is a powerful bullish catalyst for the stock.
Key Financial Metrics
Key Facts
- Revenue of $212.8M (+53% YoY) beat the $201.5M consensus by ~5.6%
- GAAP diluted EPS of $0.52 vs. -$13.10 in Q2 2025; Non-GAAP diluted EPS of $0.59 vs. $0.30
- Free cash flow of $99.6M, up 3x YoY from $32.6M
- Full-year 2026 revenue guidance raised to $856-860M (midpoint $858M, +46% YoY)
- Signed definitive agreement to acquire Cylinder Health for $105M cash, expanding into GI care
- Board approved $300M increase to share repurchase program, total authorization of $496.5M
- LTM calculated billings +52% YoY to $861.8M; client count +24% YoY to 2,929
Financial Impact
Revenue beat consensus by ~$11.3M; free cash flow of ~$99.6M; $105M cash acquisition; $300M buyback increase
Risk Factors
- Integration risk from the Cylinder Health acquisition
- Potential dilution from stock-based compensation ($19.1M in Q2 2026)
- Execution risk on the new GI Care Program launch in 2027
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-052558 |
| Document: hnge-20260729.htm | 0001628280-26-052558 |
| Document: hnge-q2202684xex992.htm | 0001628280-26-052558 |
| Document: 0001628280-26-052558-index-headers.html | 0001628280-26-052558 |
| Document: 0001628280-26-052558-index.html | 0001628280-26-052558 |
| Document: 0001628280-26-052558.txt | 0001628280-26-052558 |
| 8-K Data (Synthetic) | 0001628280-26-052558 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 16d ago | Insider Cluster | $93.73 $94.45 | ▲ +0.77% | ▼ −2.07% | $97.24 (+3.74%) |
Sep 14, 2026 17d ago | Insider Cluster | $92.39 $94.90 | ▲ +2.72% | ▲ +1.90% | $97.24 (+5.25%) |
Sep 11, 2026 20d ago | Insider Cluster | $94.79 $94.45 | ▲ +0.36% | ▲ +2.02% | $97.24 (−2.58%) |
Sep 1, 2026 4w ago | 144 | $91.85 $88.26 | ▼ −3.91% | ▼ −2.95% | $97.24 (+5.87%) |
Aug 20, 2026 6w ago | 144 | $88.42 $87.35 | ▼ −1.21% | ▼ −1.68% | $97.24 (+9.98%) |
Aug 4, 2026 8w ago | 8-K | $80.79 $86.32 | ▲ +6.84% | ▲ +6.49% | $97.24 (+20.36%) |
Jul 10, 2026 12w ago | Insider Cluster | $88.80 $85.98 | ▲ +3.18% | ▲ +2.62% | $97.24 (−9.50%) |
Jul 2, 2026 13w ago | Insider Cluster | $84.05 $89.92 | ▼ −6.98% | ▼ −6.05% | $97.24 (−15.69%) |
Jul 2, 2026 13w ago | Insider Cluster | $84.05 $89.92 | ▼ −6.98% | ▼ −6.05% | $97.24 (−15.69%) |
Jun 30, 2026 13w ago | Insider Cluster | $83.00 $88.52 | ▼ −6.65% | ▼ −6.05% | $97.24 (−17.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access